Bibliographic Details
| Title: |
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer. |
| Authors: |
Chipidza, Fallon E.1 fchipidza@dfci.harvard.edu, Alshalalfa, Mohammed1,2, Mahal, Brandon A.1, Karnes, R. Jeffrey3, Yang Liu4, Davicioni, Elai4, Martin, Neil E.1, Mouw, Kent W.1, Feng, Felix Y.2, Nguyen, Paul L.1, Muralidhar, Vinayak1 |
| Source: |
Clinical Genitourinary Cancer. Jun2021, Vol. 19 Issue 3, p246-254. 14p. |
| Database: |
Academic Search Ultimate |
